Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Intensive Care Medicine
Erschienen in: Intensive Care Medicine 3/2013

01.03.2013 | Original

Research participants’ opinions of delayed consent for a randomised controlled trial of glucose control in intensive care

verfasst von: J. E. Potter, S. McKinley, A. Delaney

Erschienen in: Intensive Care Medicine | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Critically ill patients are often unable to give informed consent to participate in clinical research. A process of delayed consent, enrolling patients into clinical trials and obtaining consent as soon as practical from either the participant or their substitute decision maker, has sometimes been used. The objective of this study was to determine the opinion of participants, previously enrolled in the NICE-SUGAR study, of the delayed consent process.

Methods

This observational study was conducted from 2009 to 2010 in the ICU of a tertiary referral hospital in Australia. Participants who were enrolled in the NICE-SUGAR study with delayed consent who survived, were cognitively intact, and proficient in English were posted a questionnaire regarding their opinion of the delayed consent process. The questionnaire was returned by post, fax, email, or completed during a telephone interview.

Results

Of 298 eligible participants, 210 responded, with an overall response rate of 79 %. Delayed consent to participate in the NICE-SUGAR study was obtained from participants (57/210; 27.1 %) or the substitute decision maker (152/210; 72.4 %). Most respondents (195/204; 95.6 %) would have consented to participate in the NICE-SUGAR study if asked before enrolment; most (163/198; 82.3 %) ranked first “the person who consented on their behalf for the NICE Study” as most preferred to make decisions, should they be unable; and most (177/202; 87.6 %) agreed with the decision made by their relative.

Conclusion

Delayed consent to participate in a clinical trial that includes critically ill patients is acceptable from research participant’s perspectives.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Annane D, Outin H, Fisch C, Bellissant E (2004) The effect of waiving consent on enrollment in a sepsis trial. Intensive Care Med 30:321–324PubMedCrossRef
2.
Cooke CR, Erickson SE, Watkins TR, Matthay MA, Hudson LD, Rubenfeld GD (2010) Age, sex, and race-based differences among patients enrolled versus not enrolled in acute lung injury clinical trials. Crit Care Med 38:1450–1457PubMedCrossRef
3.
McAdam JL, Dracup KA, White DB, Fontaine DK, Puntillo KA (2010) Symptom experiences of family members of intensive care unit patients at high risk for dying. Crit Care Med 38:1078–1085PubMedCrossRef
4.
Pochard F, Azoulay E, Chevret S, Lemaire F, Hubert P, Canoui P, Grassin M, Zittoun R, le Gall JR, Dhainaut JF, Schlemmer B, French FG (2001) Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity. Crit Care Med 29:1893–1897PubMedCrossRef
5.
Pochard F, Darmon M, Fassier T, Bollaert PE, Cheval C, Coloigner M, Merouani A, Moulront S, Pigne E, Pingat J, Zahar JR, Schlemmer B, Azoulay E (2005) Symptoms of anxiety and depression in family members of intensive care unit patients before discharge or death. A prospective multicenter study. J Crit Care 20:90–96PubMedCrossRef
6.
Mehta S, Pelletier FQ, Brown M, Ethier C, Wells D, Burry L, Macdonald R (2012) Why substitute decision makers provide or decline consent for ICU research studies: a questionnaire study. Intensive Care Med 38:47–54PubMedCrossRef
7.
NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY-S, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297CrossRef
8.
RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627–1638CrossRef
9.
SAFE Study Investigators, Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247–2256CrossRef
10.
11.
Ciroldi M, Cariou A, Adrie C, Annane D, Castelain V, Cohen Y, Delahaye A, Joly LM, Galliot R, Garrouste-Orgeas M, Papazian L, Michel F, Barnes NK, Schlemmer B, Pochard F, Azoulay E, Famirea Study Group (2007) Ability of family members to predict patient’s consent to critical care research. Intensive Care Med 33:807–813CrossRef
12.
Coppolino M, Ackerson L (2001) Do surrogate decision makers provide accurate consent for intensive care research? Chest 119:603–612PubMedCrossRef
13.
Scales DC, Smith OM, Pinto R, Barrett KA, Friedrich JO, Lazar NM, Cook DJ, Ferguson ND (2009) Patients’ preferences for enrolment into critical-care trials. Intensive Care Med 35:1703–1712PubMedCrossRef
14.
Stephenson AC, Baker S, Zeps N (2007) Attitudes of relatives of patients in intensive care and emergency departments to surrogate consent to research on incapacitated participants. Crit Care Resusc 9:40–50PubMed
15.
NICE-SUGAR Study Investigators (2005) The normoglycemia in intensive care evaluation (NICE) (ISRCTN04968275) and survival using glucose algorithm regulation (SUGAR) Study: development, design and conduct of an international multi-center, open label, randomized controlled trial of two target ranges for glycemic control in intensive care unit patients. Am J Resp Crit Care Med 172:1358–1359
16.
17.
Burns KE, Magyarody NM, Duffett M, Nisenbaum R, Cook DJ (2011) Attitudes of the general public toward alternative consent models. Am J Crit Care 20:75–83PubMedCrossRef
18.
Rose L, Burns KE, Smith OM, Marshall JC (2009) Quantifying threats to the feasibility of clinical trials in critically ill patients. Am J Resp Crit Care Med 179 (1 Meeting Abstracts): A1580
19.
Burns KE, Zubrinich C, Marshall J, Cook D (2009) The ‘Consent to Research’ paradigm in critical care: challenges and potential solutions. Intensive Care Med 35:1655–1658PubMedCrossRef
Metadaten
Titel
Research participants’ opinions of delayed consent for a randomised controlled trial of glucose control in intensive care
verfasst von
J. E. Potter
S. McKinley
A. Delaney
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 3/2013
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-012-2732-8

Weitere Artikel der Ausgabe 3/2013

Intensive Care Medicine 3/2013 Zur Ausgabe

Correspondence

Anthrax infection in an intravenous drug user

Original

Intensive care unit environment may affect the course of delirium

Correspondence

Accuracy of urine NGAL commercial assays in critically ill patients

Year in Review 2012

Year in review in Intensive Care Medicine 2012. II: Pneumonia and infection, sepsis, coagulation, hemodynamics, cardiovascular and microcirculation, critical care organization, imaging, ethics and legal issues

Experimental

Carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine kidney ischemia/reperfusion injury

Correspondence

Voriconazole-induced bradycardia without QT interval prolongation: a possible non-concentration-dependent adverse effect

Neu im Fachgebiet AINS

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise